Correlation Between Zaptec AS and Hansa Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zaptec AS and Hansa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zaptec AS and Hansa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zaptec AS and Hansa Biopharma AB, you can compare the effects of market volatilities on Zaptec AS and Hansa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zaptec AS with a short position of Hansa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zaptec AS and Hansa Biopharma.

Diversification Opportunities for Zaptec AS and Hansa Biopharma

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Zaptec and Hansa is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Zaptec AS and Hansa Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hansa Biopharma AB and Zaptec AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zaptec AS are associated (or correlated) with Hansa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hansa Biopharma AB has no effect on the direction of Zaptec AS i.e., Zaptec AS and Hansa Biopharma go up and down completely randomly.

Pair Corralation between Zaptec AS and Hansa Biopharma

Assuming the 90 days trading horizon Zaptec AS is expected to under-perform the Hansa Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Zaptec AS is 1.15 times less risky than Hansa Biopharma. The stock trades about -0.08 of its potential returns per unit of risk. The Hansa Biopharma AB is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  3,268  in Hansa Biopharma AB on August 25, 2024 and sell it today you would lose (200.00) from holding Hansa Biopharma AB or give up 6.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.47%
ValuesDaily Returns

Zaptec AS  vs.  Hansa Biopharma AB

 Performance 
       Timeline  
Zaptec AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zaptec AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Hansa Biopharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hansa Biopharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Zaptec AS and Hansa Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zaptec AS and Hansa Biopharma

The main advantage of trading using opposite Zaptec AS and Hansa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zaptec AS position performs unexpectedly, Hansa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hansa Biopharma will offset losses from the drop in Hansa Biopharma's long position.
The idea behind Zaptec AS and Hansa Biopharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal